Critical Care Medicine,
Journal Year:
2021,
Volume and Issue:
49(10), P. 1726 - 1738
Published: May 10, 2021
OBJECTIVES:
We
performed
a
comprehensive
health
assessment
in
mechanically
ventilated
coronavirus
disease
2019
survivors
to
assess
the
impact
of
respiratory
and
skeletal
muscle
injury
sustained
during
ICU
stay
on
physical
performance
at
3
months
following
hospital
discharge.
DESIGN:
Preregistered
prospective
observational
cohort
study.
SETTING:
University
ICU.
PATIENTS:
All
patients
admitted
our
first
European
pandemic
wave.
MEASUREMENTS
AND
MAIN
RESULTS:
At
after
discharge,
46
underwent
(6-min
walking
distance,
Medical
Research
Council
sum
score
handgrip
strength),
full
pulmonary
function
test,
chest
CT
scan
which
was
used
analyze
architecture.
In
addition,
patient-reported
outcomes
measures
were
collected.
Physical
assessed
by
6-minute
distance
below
80%
predicted
48%
patients.
Patients
with
impaired
had
more
weakness
(Medical
53
[51–56]
vs
59
[56–60];
p
<
0.001),
lower
lung
diffusing
capacity
(54%
[44–66%]
68%
[61–72%
predicted];
=
0.002),
higher
intermuscular
adipose
tissue
area
(
0.037).
Reduced
increased
independently
associated
performance.
CONCLUSIONS:
disability
is
common
severe
survivors.
Lung
suggesting
key
role
for
quality
functional
disability.
Pulmonology,
Journal Year:
2021,
Volume and Issue:
27(6), P. 518 - 528
Published: June 24, 2021
There
is
evidence
of
short-
and
long-term
impairment
physical
performance
in
patients
with
COVID-19
infection,
but
a
verification
measures
this
condition
lacking.
We
reviewed
the
used
to
assess
these
patients.
Secondary
targets
were
exercise
or
daily
life
activities
induced
symptoms.Medline,
CINAHL,
Pedro
databases
searched
from
January
2020
February
2021
for
articles
English
language.
Two
investigators
independently
conducted
search,
screened
all
titles
and/or
abstracts
based
on
inclusion
criteria
scored
studies.
The
quality
studies
was
evaluated
by
two
reviewers
according
NIH
assessment
tool
observational
cohort
cross-sectional
Discrepancies
resolved
through
consensus.Out
156
potentially
relevant
articles,
31
(8
cross-sectional),
1
randomized
controlled
trial,
protocol
included.
most
evaluable
judged
as
low
(11
studies)
fair
(14
studies).
Sample
sizes
ranged
14
20,889
among
28
reported
measures,
Barthel
Index
(42.4%
studies),
Six-Minute
Walking
Distance
Test
(36.4%),
Short
Physical
Performance
Battery
(21.2%)
1-Minute
Sit-to-Stand
(12.1%)
used.
Fifteen%
36%
desaturation
dyspnoea
when
performing
assessments,
respectively.
Other
symptoms
fatigue
pain.
Studies
wide
ranges
compared
"reference"
values
(range
mean
median
vs
"reference
values":
11-77
100
points
Index;
11-22
22-37
repetitions/min
1m-STS;
0.5-7.9
11.4
±
1.3
SPPB;
45-223
380-782
m
6MWT
respectively).This
review
found
that
variety
functional
status
tests
have
been
used,
making
comparisons
difficult
between
These
show
However,
fair.
Critical Care Explorations,
Journal Year:
2021,
Volume and Issue:
3(3), P. e0353 - e0353
Published: March 1, 2021
To
investigate
implementation
of
evidence-based
and
supportive
cares
in
ICUs,
such
as
the
ABCDEF,
nutrition
therapy,
ICU
diary,
for
patients
with
coronavirus
disease
2019
infection
ICUs
their
association
clinical
practice
setting.A
worldwide,
2-day
point
prevalence
study.The
study
was
carried
out
on
June
3,
2020,
July
1,
2020.
A
total
212
38
countries
participated.
Clinicians
each
participating
completed
web-based
online
surveys.The
2019.None.The
rate
elements
ABCDEF
bundle,
other
care
measures,
implementation-associated
structures
were
investigated.
Data
collected
262
patients,
whom
47.3%
underwent
mechanical
ventilation
4.6%
treated
extracorporeal
membrane
oxygenation.
Each
element
implemented
following
percentages
patients:
(regular
pain
assessment),
45%;
B
(both
spontaneous
awakening
breathing
trials),
28%;
C
sedation
52%;
D
delirium
35%;
E
(early
mobility
exercise),
47%;
F
(family
engagement
empowerment),
16%.
The
4%
8%
Supportive
care,
protein
provision
throughout
stay
(under
1.2
g/kg
more
than
50%
patients)
introduction
diary
(25%),
infrequent.
Implementation
rates
higher
specific
protocols
fewer
beds
exclusively
infection.
Element
at
a
that
had
assigned
them.This
showed
low
bundle.
Specific
number
reserved
might
be
key
factors
delivering
appropriate
care.
JMIR Rehabilitation and Assistive Technologies,
Journal Year:
2022,
Volume and Issue:
9(3), P. e36836 - e36836
Published: July 19, 2022
Between
30%
to
76%
of
COVID-19
patients
have
persistent
physical
and
mental
symptoms,
sometimes
up
9
months
after
acute
COVID-19.
Current
rehabilitation
is
mostly
focused
on
the
whereas
experts
agreed
need
for
a
biopsychosocial
approach.
A
novel
approach
such
as
virtual
reality
(VR)
at
home
might
benefit
therapists,
especially
considering
expected
rush
with
post-COVID-19
condition
needing
rehabilitation.The
aim
this
study
was
investigate
feasibility
self-administered
VR
exercises
condition.This
single-arm
in
an
outpatient
care
setting.
Patients
who
needed
physiotherapy
because
were
included
determined
by
treating
physiotherapist.
Participants
performed
period
6
weeks
allowed
perform
exercise
through
applications
available
platform
reduce
stress
anxiety
promote
cognitive
functioning.
The
main
outcomes
related
(ie,
duration
frequency
use),
safety
adverse
events),
patient
satisfaction,
reasons
withdraw.
Physical
performance,
daily
activities,
functioning,
depression,
quality
life
measured
before
after.In
total,
48
included;
1
(2%)
did
not
start
VR,
7
(15%)
withdrew,
due
dizziness.
Almost
70%
(33/47)
participants
reported
experiencing
any
event
during
exercising.
However,
only
25%
(9/36)
recalled
these
events
end
intervention
period.
majority
(27/36,
75%)
described
having
positive
influence
their
recovery,
global
satisfaction
score
67%.
average
use
30
minutes
per
session,
3-4
times
week
3-6
weeks.
overall
almost
equally
distributed
over
3
sets
(physical,
relaxing,
cognitive).
seemed
decrease
time,
relaxation
remained
stable.
performance
significantly
improved
weeks.VR
feasible
safe
good
acceptance
significant
percentage
condition.ClinicalTrials.gov
NCT04505761;
https://clinicaltrials.gov/ct2/show/NCT04505761.
